The deputies want the government to answer six questions, one of them regarding the incorporation in the SUS of a specific product linked to only one manufacturer and not related to the active ingredient

Anvisa proposes exclusive process for the regulation and experts point out impact on the sector

Preclinical study suggests CBD may reduce intestinal spasms and diarrhea, with a direct effect on gastrointestinal motility

Learn how they relate to cannabinoids and how they act, through the entourage effect, in our bodies

Find out which countries allow the entry of cannabidiol and how airline transport rules work for this product

CBD causes a myriad of positive effects on the human body, such as reducing anxiety, pain, and stress.

The CBD Pillow releases microdoses of CBD throughout the night, so you can have a relaxing sleep

The study also suggests that when the activation of these cells is reduced, the inflammation caused by seizure episodes in the brain can also be alleviated.

Some research shows that CBD has anti-inflammatory and immunosuppressive properties

Despite technical feasibility, Anvisa conditions the production of cannabidiol on the publication of a specific regulation, with validity in 90 days

The startup's investment combines cutting-edge technology and sustainability to produce high-performance fibers, positioning Portugal at the forefront of the textile industry

Understand cannabidiol, its functioning in the body, and potential therapeutic benefits

Ease Labs is the second among the five companies with the highest market volume to announce price reductions

Understand everything about cannabidiol

With clinical sensitivity and active listening, a pediatrician reports how cannabidiol has transformed the lives of children with epilepsy, autism, and other complex neurological conditions, as well as their families

Update of the RDC included in the Regulatory Agenda 2024-2025 is expected for next year

While we believe it is unlikely that the popularity of CBD will diminish anytime soon, it seems increasingly likely that other cannabinoids will be vying for our attention in the near future

Thiago Campos advocates for the extension of the regulation deadline and reinforces the importance of social listening in the process

Research from USP with an animal model reveals that cannabidiol (CBD) can simultaneously alleviate neuropathic pain and symptoms of depression, showing itself as a promising therapeutic alternative to traditional medications

Public consultation is launched for preliminary version, but sector agents' criticisms question the scope and composition of the medication